Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 63.6%
Negative

Negative
Zacks Investment Research
yesterday
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash
Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash
Neutral
Seeking Alpha
yesterday
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q4 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
2 days ago
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE). The investigation focuses on Chemed's executive officers and whether investor losses may be recovered under federal securities laws.
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Neutral
Seeking Alpha
2 days ago
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
3 days ago
Chemed Reports Fourth-Quarter 2025 Results
CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period.
Chemed Reports Fourth-Quarter 2025 Results
Negative
The Motley Fool
12 days ago
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
Barington Companies Management initiated a 13,000-share position in Chemed during the fourth quarter. The estimated trade value was $5.56 million.
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
Neutral
GlobeNewsWire
15 days ago
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
Neutral
GlobeNewsWire
1 month ago
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
Positive
Zacks Investment Research
2 months ago
Should Investors Hold Chemed Stock in Their Portfolio Now?
CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.
Should Investors Hold Chemed Stock in Their Portfolio Now?
Positive
Zacks Investment Research
2 months ago
Chemed (CHE) Upgraded to Buy: Here's What You Should Know
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemed (CHE) Upgraded to Buy: Here's What You Should Know